Transplant characteristics
| . | N . |
|---|---|
| Donor type | |
| MRD | 15 |
| MUD | 35 |
| MMRD | 45 |
| CBU | 5 |
| Stem cell source | |
| PB | 87 |
| BM | 8 |
| CBU | 5 |
| Conditioning regimen | |
| MAC | 78 |
| RIC | 22 |
| GvHD prophylaxis (A) | |
| PT-Cy | 59 |
| ATG | 25 |
| PT-Cy and ATG | 7 |
| None | 9 |
| GvHD prophylaxis (B) | |
| Rapamycin | 81 |
| Cyclosporine | 19 |
| . | N . |
|---|---|
| Donor type | |
| MRD | 15 |
| MUD | 35 |
| MMRD | 45 |
| CBU | 5 |
| Stem cell source | |
| PB | 87 |
| BM | 8 |
| CBU | 5 |
| Conditioning regimen | |
| MAC | 78 |
| RIC | 22 |
| GvHD prophylaxis (A) | |
| PT-Cy | 59 |
| ATG | 25 |
| PT-Cy and ATG | 7 |
| None | 9 |
| GvHD prophylaxis (B) | |
| Rapamycin | 81 |
| Cyclosporine | 19 |
ATG, antithymocyte globulin; BM, bone marrow; CBU, cord blood unit; GVHD, graft-versus-host disease; MAC, myeloablative conditioning; MMRD, mismatched related donors; MRD, matched related donor; MUD, matched unrelated donor; PB, peripheral blood; PT-Cy, posttransplant cyclophosphamide; RIC, reduced intensity conditioning.